Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 8 for:    brincidofovir adenovirus

Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02596997
Expanded Access Status : Available
First Posted : November 4, 2015
Last Update Posted : May 24, 2018
Sponsor:
Information provided by (Responsible Party):
Chimerix

Brief Summary:
Provide patients with serious AdV infection or disease access to treatment with BCV.

Condition or disease Intervention/treatment
Adenovirus Drug: Brincidofovir

Layout table for study information
Study Type : Expanded Access
Official Title: An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Resource links provided by the National Library of Medicine



Intervention Details:
  • Drug: Brincidofovir
    Up to 100mg Brincidofovir twice weekly, not to exceed a total dose of 200mg each week
    Other Name: BCV CMX001

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   2 Months and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids
  • Able to swallow medication, either tablet or liquid

Exclusion Criteria:

  • Previous dosing with Brincidofovir
  • If female, not pregnant or trying to become pregnant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02596997


Contacts
Layout table for location contacts
Contact: Garrett Nichols, MD 919-287-6006 gnichols@chimerix.com

  Hide Study Locations
Locations
Layout table for location information
United States, Arkansas
University of Arkansas Medical Center
Little Rock, Arkansas, United States, 72205
Principal Investigator: Mary Burgess, MD         
United States, California
Children's Hospital LA
Los Angeles, California, United States, 90027
Principal Investigator: Hisham Abdel-Azim, MD         
UCLA Medical Center
Los Angeles, California, United States, 90095
Principal Investigator: Drew Winston, MD         
Children's Hospital of Orange County
Orange, California, United States, 92868
Principal Investigator: Steven Neudorf, MD         
Pediatric Stem Cell Transplantation Stanford University
Palo Alto, California, United States, 94304
Principal Investigator: Rajni Agarwal, MD         
Stanford University
Palo Alto, California, United States, 94304
Principal Investigator: Janice Brown, MD         
UC San Diego Moores Cancer center
San Diego, California, United States, 92037
Principal Investigator: Randy Taplitz, MD         
University of California San Francisco Benioff Children's Hospital
San Francisco, California, United States, 94143
Principal Investigator: Christopher Dvorak, MD         
United States, Colorado
Children's Hospital Colorado
Aurora, Colorado, United States, 80045
Principal Investigator: Roger Giller, MD         
United States, District of Columbia
Children's National Medical Center
Washington, District of Columbia, United States, 20010
Principal Investigator: Benjamin Hanisch, MD         
United States, Florida
University of Florida
Gainesville, Florida, United States, 32610
Principal Investigator: William Slayton, MD         
All Childrens Research Institute
Saint Petersburg, Florida, United States, 33606
Principal Investigator: Benjamin Oshrine         
All Children's Research Institute
Saint Petersburg, Florida, United States, 33701
Principal Investigator: Aleksandra Petrovic, MD         
United States, Georgia
Emory University-AFLAC Cancer and Blood Disorder Clinic
Atlanta, Georgia, United States, 30322
Principal Investigator: Amelia Langston, MD         
United States, Illinois
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611
Principal Investigator: William Muller, MD         
University of Chicago
Chicago, Illinois, United States, 60637
Principal Investigator: Kate Mullane, MD         
United States, Kansas
Children's Mercy Hospital
Kansas City, Kansas, United States, 64108
Principal Investigator: Dwight Yin, MD         
United States, Kentucky
University of Louisville-Kosair Childrens Hospital
Louisville, Kentucky, United States, 40292
Principal Investigator: Michael Huang, MD         
United States, Louisiana
Children's Hospital New Orleans
New Orleans, Louisiana, United States, 70118
Principal Investigator: Lolie Yu, MD         
United States, Massachusetts
Brigham & Woman's Hospital/Boston
Boston, Massachusetts, United States, 02115
Principal Investigator: Francisco Marty, MD         
United States, Michigan
Michigan State/Spectrum Health
Grand Rapids, Michigan, United States, 49503
Principal Investigator: Ulrich Duffner, MD         
United States, Missouri
Washington University
Saint Louis, Missouri, United States, 63130
Principal Investigator: Rachel Orscheln, MD         
United States, Nebraska
University of Nebraska
Omaha, Nebraska, United States, 68198-5400
Principal Investigator: Diana Florescu, MD         
United States, New Jersey
Hackensack University MC
Hackensack, New Jersey, United States, 07601
Principal Investigator: Alfred Gillio, MD         
United States, New York
The Children's Hospital at Montefiore
Bronx, New York, United States, 10467
Principal Investigator: Kris Mahadeo, MD         
Weill Conrell Medical Center
New York, New York, United States, 10021
Principal Investigator: Rosemary Soave, MD         
Morgan Stanley Children's Hospital
New York, New York, United States, 10032
Principal Investigator: Prakash Satwani, MD         
Memorial Sloan Kettering
New York, New York, United States, 10065
Principal Investigator: Genovefa Papanicolaou, MD         
New York Medical College-Maria Fareri Childrens hospital
New York, New York, United States, 10595
Principal Investigator: Allyson Flower         
New York Medical College, Maria Fareri Children's Hospital
Valhalla, New York, United States, 10595
Principal Investigator: Rehzad Bidadi, MD         
United States, North Carolina
Levine Children's Hospital
Charlotte, North Carolina, United States, 28203
Principal Investigator: Jeffrey Ho, MD         
Duke University Medical System
Durham, North Carolina, United States, 27710
Principal Investigator: Vinod Prasad, MD         
United States, Ohio
Cincinnatti Children's Hospital
Cincinnati, Ohio, United States, 45229
Principal Investigator: Micheal Grimley, MD         
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Principal Investigator: Christine Koval, MD         
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205
Principal Investigator: Hemalatha Rangarajan, MD         
United States, Pennsylvania
The Childrens hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Principal Investigator: Nancy Bunin, MD         
United States, Tennessee
Methodist University Hospital-BMT program west clinic
Memphis, Tennessee, United States, 38104
Principal Investigator: Jason Chandler, MD         
St. Jude Research Hospital
Memphis, Tennessee, United States, 38105
Principal Investigator: Gabriela Maron, MD         
United States, Texas
UT Southwestern Medical Center
Dallas, Texas, United States, 75235
Principal Investigator: Victor Aquino, MD         
Cook Children's Health Care System
Fort Worth, Texas, United States, 76104
Principal Investigator: Richard Howrey, MD         
Baylor College of Medicine-Infectious Disease
Houston, Texas, United States, 77030
Principal Investigator: Flor de Maria Munoz, MD         
University of Texas, MD Anderson Cancer Center
Houston, Texas, United States, 77030
Principal Investigator: Roy Chemaly, MD         
Methodist Children's Hospital of South Texas
San Antonio, Texas, United States, 78229
Principal Investigator: Troy Quigg, MD         
United States, Washington
University of Washington/ Seattle Children's Hospital
Seattle, Washington, United States, 98105
Principal Investigator: Janet Englund, MD         
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States, 98195
Principal Investigator: Steve Pergam, MD         
United States, Wisconsin
Medical College of Wisconsin
Wauwatosa, Wisconsin, United States, 53226
Principal Investigator: Julie Talano, MD         
Sponsors and Collaborators
Chimerix

Layout table for additonal information
Responsible Party: Chimerix
ClinicalTrials.gov Identifier: NCT02596997     History of Changes
Other Study ID Numbers: CMX001-351
First Posted: November 4, 2015    Key Record Dates
Last Update Posted: May 24, 2018
Last Verified: May 2018
Keywords provided by Chimerix:
Adenovirus Brincidofovir
Additional relevant MeSH terms:
Layout table for MeSH terms
Adenoviridae Infections
DNA Virus Infections
Virus Diseases